Looking for the stocks with genuine business exposure to Urban Housing? The QuantLogix engine resolves this theme into an equal-weight research basket of liquid, US-listed names — each validated against a 5,000+ stock universe so live prices and 5-factor engine signals exist for every holding. The full basket adds a transparent trailing backtest vs the S&P 500 and a forward paper-money model record measured from the day the basket is published.
Every theme basket is AI-selected for pure-play exposure, then validated: each name must be tradable, US-listed, and covered by the QuantLogix 5-factor signal engine (Technical · Momentum · Fundamental · Options · Microstructure). Baskets are equal-weighted and scored live. Curated baskets also run in a paper-money model account — seeded once at publication, never edited, marked to market every trading day — so the record you see is a forward measurement, not just a retrospective backtest.
Which stocks have exposure to Urban Housing?
The QuantLogix engine maps liquid, US-listed names with genuine business exposure to Urban Housing — including Pultegroup, Inc. (PHM), Lennar Corporation Class A (LEN), Toll Brothers, Inc. (TOL) — into an equal-weight research basket of roughly a dozen stocks. Every constituent is validated against a 5,000+ stock universe so prices and live 5-factor engine signals exist for each name.
How is the Urban Housing basket built?
Constituents are AI-selected for pure-play exposure, validated to be tradable and signal-covered, and equal-weighted. The full basket includes the live 5-factor engine score on every holding, a transparent trailing backtest vs the S&P 500, and a forward paper-money model record measured from the day a basket is published — a research starting point, not a recommendation.
Is this investment advice?
No. Thematic baskets concentrate exposure to a single trend and can be materially more volatile than the broad market. All performance shown is hypothetical (backtest or paper-money model record), not actual trading, and past performance is not indicative of future results. Do your own research or consult a licensed advisor.